Behavioral Intervention
JASPER Intervention for Autism
This trial is testing JASPER, a play-based therapy, on young children with autism who have limited verbal skills. The therapy uses guided play to help these children improve their social and communication abilities. JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a naturalistic developmental behavioral intervention that has been found effective for promoting social communication in young children with autism.
Behavioral Intervention
DTT + JASPER for Autism
This trial aims to improve language skills in preschool children with autism using a structured teaching and social interaction-based learning program. The program is adjusted based on each child's progress. The goal is to help these children develop better communication skills and avoid being minimally verbal by age 6.
Behavioral Intervention
Word Learning Strategies for Autism
This trial aims to see if teaching strategies that help non-autistic children learn new words can also help autistic children. They will test if repeating words or quizzing the child after labeling the words is
Behavioural Intervention
Digital Game Therapy for Autism
This trial studies the effects of an app, GuessWhat, on improving communication skills in kids with autism. Families use smartphones to download the app and play games like charades, emotion guessing and quizzes.
Behavioural Intervention
AI Modules for Improving Social Communication in Autism
This trial aims to see if AI can effectively deliver interventions for individuals with autism spectrum disorder who struggle with socialization. The study will use an app on a phone or computer to provide practice and feedback on
Popular Filters
Trials for Autism Spectrum Disorder Patients
Behavioral Intervention
SDLMI + UNITED Strategy for Autism
This trial will compare the effectiveness of each intervention with and without the addition of our implementation strategy, UNITED. UNITED is a remote delivery of professional development modules specific to the intervention and active coaching as dictated by the intervention procedures.
Behavioral Intervention
Remaking Recess for Autism
This trial tests Remaking Recess, a program that helps children with autism or developmental disorders engage socially during school recess. It targets children aged 5-12 and involves training school staff to support these children in social interactions through structured play activities. Remaking Recess is designed to improve peer engagement for children with autism spectrum disorder (ASD) during recess.
Telehealth Support for Autism
This trial aims to test two online tools to help families with infants who might have autism. One tool checks how babies are developing, and the other gives parents videos and tips to help their babies communicate better. The study will see if these tools make it easier for families to get the help they need.
Behavioral Intervention
Behavioral Therapy for Autism
This trial tests a new therapy called BTIA, which helps teens with autism manage their emotions and behaviors. The therapy involves regular sessions where therapists teach both the teens and their parents how to handle frustration and improve daily functioning. The study aims to see if BTIA can reduce disruptive behaviors and help these teens function better in their everyday lives.
Behavioral Intervention
SENSE Theatre for Autism
This trial tests SENSE Theatre®, a program that uses acting to help adults with autism improve their social skills. It focuses on practicing face recognition and social interactions through repeated role-playing activities. The goal is to see if these improvements last. SENSE Theatre® is a novel intervention that combines trained peers to facilitate performance-based theatrical treatment in a supportive, community-based environment.
Trials for Asperger Syndrome Patients
Behavioral Intervention
SDLMI + UNITED Strategy for Autism
This trial will compare the effectiveness of each intervention with and without the addition of our implementation strategy, UNITED. UNITED is a remote delivery of professional development modules specific to the intervention and active coaching as dictated by the intervention procedures.
Behavioral Intervention
Remaking Recess for Autism
This trial tests Remaking Recess, a program that helps children with autism or developmental disorders engage socially during school recess. It targets children aged 5-12 and involves training school staff to support these children in social interactions through structured play activities. Remaking Recess is designed to improve peer engagement for children with autism spectrum disorder (ASD) during recess.
Telehealth Support for Autism
This trial aims to test two online tools to help families with infants who might have autism. One tool checks how babies are developing, and the other gives parents videos and tips to help their babies communicate better. The study will see if these tools make it easier for families to get the help they need.
Behavioral Intervention
Behavioral Therapy for Autism
This trial tests a new therapy called BTIA, which helps teens with autism manage their emotions and behaviors. The therapy involves regular sessions where therapists teach both the teens and their parents how to handle frustration and improve daily functioning. The study aims to see if BTIA can reduce disruptive behaviors and help these teens function better in their everyday lives.
Behavioral Intervention
SENSE Theatre for Autism
This trial tests SENSE Theatre®, a program that uses acting to help adults with autism improve their social skills. It focuses on practicing face recognition and social interactions through repeated role-playing activities. The goal is to see if these improvements last. SENSE Theatre® is a novel intervention that combines trained peers to facilitate performance-based theatrical treatment in a supportive, community-based environment.
Phase 3 Trials
Cannabinoid
Cannabidiol for Autism
This trial is testing whether a medicine called cannabidiol (CBD) can help boys aged 7-14 with autism who have severe behavior problems. CBD, which comes from the cannabis plant but doesn't make you feel 'high,' might help by calming brain activity. The goal is to see if this treatment can improve their behavior and quality of life. Cannabidiol (CBD) has been reported to be safe and well-tolerated and has shown potential in managing symptoms of autism.
Atypical Antipsychotic
Cariprazine for Pediatric Schizophrenia
This trial is testing the safety and effectiveness of cariprazine in children and teens with schizophrenia, bipolar I disorder, or autism. The goal is to see if the medication is safe and beneficial for use in these young patients.
Melatonin Receptor Agonist
Tasimelteon for Autism and Sleep Disorders
This trial is testing a daily pill called tasimelteon to help children and adults with Autism Spectrum Disorder (ASD) who have trouble sleeping. The medication aims to improve sleep by helping to regulate the body's internal clock.
Trials With No Placebo
Behavioral Intervention
SDLMI + UNITED Strategy for Autism
This trial will compare the effectiveness of each intervention with and without the addition of our implementation strategy, UNITED. UNITED is a remote delivery of professional development modules specific to the intervention and active coaching as dictated by the intervention procedures.
Behavioral Intervention
Remaking Recess for Autism
This trial tests Remaking Recess, a program that helps children with autism or developmental disorders engage socially during school recess. It targets children aged 5-12 and involves training school staff to support these children in social interactions through structured play activities. Remaking Recess is designed to improve peer engagement for children with autism spectrum disorder (ASD) during recess.
Telehealth Support for Autism
This trial aims to test two online tools to help families with infants who might have autism. One tool checks how babies are developing, and the other gives parents videos and tips to help their babies communicate better. The study will see if these tools make it easier for families to get the help they need.
Behavioral Intervention
Behavioral Therapy for Autism
This trial tests a new therapy called BTIA, which helps teens with autism manage their emotions and behaviors. The therapy involves regular sessions where therapists teach both the teens and their parents how to handle frustration and improve daily functioning. The study aims to see if BTIA can reduce disruptive behaviors and help these teens function better in their everyday lives.
Behavioral Intervention
SENSE Theatre for Autism
This trial tests SENSE Theatre®, a program that uses acting to help adults with autism improve their social skills. It focuses on practicing face recognition and social interactions through repeated role-playing activities. The goal is to see if these improvements last. SENSE Theatre® is a novel intervention that combines trained peers to facilitate performance-based theatrical treatment in a supportive, community-based environment.
Behavioural Intervention
Adaptive Autism Intervention for Toddlers with Autism
This trial tests a program to help toddlers with autism improve their social and communication skills. The program starts with play-based activities and is adjusted based on each child's progress. These activities have been shown to improve social communication in young children with autism. The goal is to find the best way to support these children in everyday settings.
View More Related Trials
Frequently Asked Questions
Introduction to autism
What are the top hospitals conducting autism research?
Autism, a complex neurological condition affecting individuals worldwide, is being met with dedicated research efforts at several prestigious hospitals. Stanford University in Stanford leads the way with seven ongoing clinical trials focused on autism. Located in the heart of Silicon Valley, this institution brings together cutting-edge technology and innovative thinking to tackle the challenges faced by individuals on the autism spectrum. Not far behind is Massachusetts General Hospital in Boston, which currently has five active autism trials underway. As one of the top-ranked hospitals in the United States, their commitment to understanding and addressing autism's complexities is evident.
Further south, Vanderbilt University Medical Center in Nashville joins this group with four ongoing autism trials. Known for its interdisciplinary approach to healthcare and research excellence, this center is committed to uncovering new insights into autism diagnosis and treatment options. Meanwhile, Yale Child Study Center in New Haven plays a vital role as well through their four active clinical trials aimed at improving our understanding of autism spectrum disorders and paving the way for more effective interventions.
On the West Coast, UCLA stands out among California's top institutions with four ongoing clinical trials focusing on Autism Spectrum Disorder (ASD). Situated amidst Los Angeles' vibrant academic community and diverse population base, UCLA researchers are exploring new avenues for early detection methods while enhancing therapeutic approaches tailored towards each individual’s unique needs.
While these hospitals have yet to conduct previous studies specifically related to autism, their current dedication substantiates their commitment towards unraveling mysteries surrounding this condition that affects millions globally. Through collaborative efforts across various disciplines including neuroscience, psychology,and genetics; these esteemed medical centers strive not only to improve quality-of-life but also foster an inclusive society where every person can thrive regardless of neurodiversity
Which are the best cities for autism clinical trials?
When it comes to autism clinical trials, several cities in the United States emerge as prominent hubs of research and development. In Houston, Texas, there are 10 active trials investigating treatments like GWP42003-P, ML-004 (IR)/(ER) tablet, and Cariprazine Flexible Dose. Stanford, California follows closely with 9 ongoing studies exploring interventions such as Zolpidem and a Mobile Game System for Potential Treatment of Developmental Delays. Phoenix, Arizona also boasts 9 active trials examining treatments like Levoleucovorin Calcium. These locations offer individuals with autism opportunities to participate in cutting-edge clinical trials aimed at advancing treatment options and improving their quality of life.
Which are the top treatments for autism being explored in clinical trials?
In the realm of autism treatment, clinical trials are paving the way for breakthroughs. One notable contender is cannabidivarin (CBDV), currently being explored in three ongoing trials. Another promising candidate is balovaptan, showing potential with two active clinical trials dedicated to autism research. Lastly, trofinetide stands out as a frontrunner, garnering attention through its involvement in multiple studies aiming to uncover effective treatments for individuals on the autism spectrum. As researchers delve deeper into these innovative therapies, hope continues to grow for improved outcomes and increased quality of life for those affected by autism.
What are the most recent clinical trials for autism?
Exciting advancements are being made in the field of autism research, with several recent clinical trials offering hope for improved treatments. These trials include a Phase 1 study investigating a new treatment for autism, as well as Phase 2 studies exploring the effectiveness of pimavanserin tartrate, zolpidem, suvorexant, and diphenhydramine in managing symptoms associated with autism. By evaluating these potential therapies, researchers aim to enhance our understanding of autism and develop more targeted approaches for individuals on the spectrum.
What autism clinical trials were recently completed?
Several clinical trials focusing on autism have recently concluded, representing significant progress in the field. These completed trials include a study investigating the effectiveness of a novel intervention for enhancing social communication skills in children with autism, led by researchers at Stanford University. In addition, a trial examining the impact of early intensive behavioral intervention on language development and adaptive behavior in toddlers with autism was successfully completed at Boston Children's Hospital. Furthermore, scientists from the University of California conducted a trial evaluating a new pharmacological treatment aimed at reducing repetitive behaviors associated with autism spectrum disorder. These recent advancements highlight ongoing efforts to explore innovative approaches for improving outcomes and quality of life for individuals with autism.